Phase 2 Study Eyed for One of Leading COVID-19 Vaccine Candidates

Clalit Health Maintenance Organization lab technicians wearing protective gear handle coronavirus tests in Lod

Clalit Health Maintenance Organization lab technicians wearing protective gear handle coronavirus tests in Lod

Scientists at Oxford are so confident about the vaccine working that they have already started mass producing it even before the clinical trial phase is stated to begin. "There are now five such trials". There are three phases.

That one version of their vaccine is about to enter a new phase: human trials, which will be taking place in May with 120 people in Australia. For example, one such risk could be the effect of "immune enhance", which is that the vaccine, by contrast, interferes with the immune response.

Sarah Gilbert from Oxford University is claiming that her team can ready a Coronavirus vaccine by September this year.

The possibility of a future second wave of the virus keeps them going.

During Friday's Downing Street press briefing, the government's Chief Scientific Adviser Patrick Vallance noted that the number of new cases reported in hospitals has become flat over the last few days, and "we would expect this to start decreasing in terms of total number of cases".

The big question is whether this experimental vaccine will actually work.

Biotech company Moderna has been awarded funding from the US Biomedical Advanced Research and Development Authority (BARDA) to accelerate development of its coronavirus vaccine, in a deal worth up to $483m.

BC health officials update COVID-19 modelling
Jock Finlayson, executive vice-president and chief policy officer of the Business Council of British Columbia, acknowledged Dr. But Quebec's director of public health says the number of daily new cases in the province should be declining soon.

The two vaccines were developed respectively by Wuhan Institute of Biological Products Co., Ltd of Sinopharm and Sinovac Research & Development Co., Ltd together with research institutes.

The WHO is creating a platform for everybody creating Covid-19 vaccines to share their plans and preliminary findings, according to Gilbert.

A decade compressed into a year and a half The time to develop and market a vaccine is widely seen to be between 10 to 15 years.

Chinese President Xi Jinping has also repeatedly stressed the need to step-up development of vaccines for COVID-19. "There won't be enough for everywhere by then, but the more manufacturing we can do starting from now, then the more doses there will be".

But no deal has been done by Whitehall to secure supply of any vaccine doses. They provided an "investigational vaccine" for Ebola to the Democratic Republic of Congo in November 2019 to combat an outbreak there, according to the company site. Should we give it to frontline healthcare professionals such as doctors and nurses first?

"When complete, our DNA-based vaccine will be administered non-invasively as a nasal spray that delivers nanomedicine engineered to immunize and decrease COVID-19 infections", said Slavcev, who specializes in designing vaccines, pharmaceuticals and gene-therapy treatments. "And that's a decision that is best made before you actually have a vaccine in hand - because once you have it, it's going to be hard to respond to demand in a fair and effective manner".

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.